崔润泽

润泽 崔 is currently the Director of Investor Relations at OncoC4, Inc., a position they have held since 2025. Prior to this role, they served as the Vice President of Strategic Investment at SINOVAC from 2021 to 2024, and gained experience as an Analyst at 3E Bioventures Capital between 2019 and 2020. 润泽 also completed an internship at 济峰资本 in 2017. They hold a Ph.D. in Neurobiology from 复旦大学, where they studied from 2012 to 2019, and a Bachelor’s degree in Biological/Biosystems Engineering from 西南交通大学, completed in 2012. Currently, 润泽 is pursuing dual MBA degrees at both 美国康奈尔大学 and 清华大学五道口金融学院.